Difficulty: Medium
Average Score: 91%
Testbank
Which is the primary effect of central-acting sympatholytics in a client who exhibits hypertension and anxiety?
Correct answer
D
Rationale
D: Block receptors for norepinephrine in the brain. Central-acting sympatholytics primarily function by blocking norepinephrine receptors in the central nervous system, leading to decreased sympathetic outflow, which effectively lowers blood pressure and alleviates anxiety symptoms in hypertensive clients.
A: Vasoconstriction and reduction of blood pressure and heart rate. This option incorrectly suggests that central-acting sympatholytics cause vasoconstriction; instead, they promote vasodilation through central mechanisms, reducing blood pressure and heart rate.
B: Central-acting sympatholytics induce sedation and fatigue. While sedation may occur, it is not the primary effect of these medications; their main role is to modulate sympathetic nervous system activity to manage hypertension and anxiety.
C: Affects kidneys and reduces activity of renin. This choice misrepresents the primary mechanism of action, as central-acting sympatholytics primarily act on the central nervous system rather than directly affecting renal function or renin activity.
A: Vasoconstriction and reduction of blood pressure and heart rate. This option incorrectly suggests that central-acting sympatholytics cause vasoconstriction; instead, they promote vasodilation through central mechanisms, reducing blood pressure and heart rate.
B: Central-acting sympatholytics induce sedation and fatigue. While sedation may occur, it is not the primary effect of these medications; their main role is to modulate sympathetic nervous system activity to manage hypertension and anxiety.
C: Affects kidneys and reduces activity of renin. This choice misrepresents the primary mechanism of action, as central-acting sympatholytics primarily act on the central nervous system rather than directly affecting renal function or renin activity.